Glutamate-Glutamine Cycling (VCYC) during Cocaine Abstinence using 1H-MRS

Conditions

Addictive Behaviors | Alcohol Addiction | Mental Health & Behavioral Research

Volunteers
Health Professionals

What is the purpose of this trial?

This study is designed to look at the relationship between brain glucose utilization, neurotransmission (e.g., glutamate, also known as the main excitatory amino-acid neurotransmitter in the brain), and synaptic density. This relationship will be explored in the brain's prefrontal cortex, an area important in decision-making and impulsivity.

Ages
18 years - 55 years
Gender
Both

Find out more about who can participate in this trial

Trial with
National Institute on Drug Abuse (NIDA)
Start Date
08/07/2019
End Date
01/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Gustavo A. Angarita, MD
Assistant Professor of Clinical Psychiatry; Director, Yale Cocaine Research Clinic, Psychiatry; Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry; Medical Director, Forensic Drug Diversion Clinic (ForDD)

Sub-Investigators

Last Updated
07/15/2021
Study HIC
#2000025430